Researcher
Jenny Sprooten
- Disciplines:Oncology, Immunology, Molecular and cell biology, Bioinformatics and computational biology, Medical systems biology
Affiliations
- Laboratory of Cell Stress & Immunity (Division)
Member
From1 Mar 2020 → 16 Sep 2022 - Laboratory of Cell Death Research & Therapy (VIB-KU Leuven) (Division)
Member
From17 Sep 2018 → 29 Feb 2020
Projects
1 - 2 of 2
- Revealing the cancer cell-intrinsic immunotherapy targets in glioblastoma using reverse translational approaches.From11 Oct 2023 → TodayFunding: BOF - postdoctoral mandates
- REVERSE TRANSLATIONAL DESIGNING OF THE NEXT-GENERATION ANTICANCER DC VACCINATIONS: Mechanisms and beyondFrom22 Aug 2018 → 10 Oct 2023Funding: BOF - doctoral mandates, Foundations, funds and other with scientific goal
Publications
1 - 10 of 19
- Lymph node and tumor-associated PD-L1+macrophages antagonize dendritic cell vaccines by suppressing CD8+T cells(2024)
Authors: Jenny Sprooten, Isaure Vanmeerbeek, Sabine Tejpar, Steven De Vleeschouwer, Abhishek Garg
- The cell stress and immunity cycle in cancer: Toward next generation of cancer immunotherapy(2024)
Authors: Isaure Vanmeerbeek, Jenny Sprooten, Stefan Naulaerts, Abhishek Garg
Pages: 71 - 93 - Trial watch: chemotherapy-induced immunogenic cell death in oncology(2023)
Authors: Jenny Sprooten, Isaure Vanmeerbeek, Stefan Naulaerts, Lisa Kinget, An Coosemans, Steven De Vleeschouwer, Els Wauters, Sabine Tejpar, Benoit Beuselinck, Sigrid Hatse, et al.
- Single cell dynamics of tumor specificity vs bystander activity in CD8+ T cells define the diverse immune landscapes in colorectal cancer(2023)
Authors: Sara Verbandt, Isaure Vanmeerbeek, Jenny Sprooten, Gert De Hertogh, Xavier Sagaert, Albert Wolthuis, Stefan Naulaerts, Sabine Tejpar, Abhishek Garg
- REVERSE TRANSLATIONAL DESIGNING OF THE NEXT-GENERATION ANTICANCER DC VACCINATIONS: Mechanisms and beyond(2023)
Authors: Jenny Sprooten, Abhishek Garg, Susan Schlenner, Patrizia Agostinis
- Multiomics and spatial mapping characterizes human CD8+T cell states in cancer(2023)
Authors: Stefan Naulaerts, Daniel Borras Morales, Julie Messiaen, Isaure Vanmeerbeek, Jenny Sprooten, Dena Panovska, Yannick Van Herck, Lendert Gelens, Tom Venken, Oliver Bechter, et al.
- Trial watch: Dendritic cell (DC)-based immunotherapy for cancer(2022)
Authors: Jenny Sprooten, Stefan Naulaerts, Benoit Beuselinck, An Coosemans, Lisa Kinget, Sandra Tuyaerts, Steven De Vleeschouwer, Abhishek Garg
- Early memory differentiation and cell death resistance in T cells predicts melanoma response to sequential anti-CTLA4 and anti-PD1 immunotherapy (vol 22, pg 108, 2021)(2022)
Authors: Jenny Sprooten, Oliver Bechter, Sabine Tejpar, Abhishek Garg
Pages: 260 - 260 - The Interface of Tumour-Associated Macrophages with Dying Cancer Cells in Immuno-Oncology(2022)
Authors: Isaure Vanmeerbeek, Jenny Sprooten, Stefan Naulaerts, Abhishek Garg
- A first-in-class, non-invasive, immunodynamic biomarker approach for precision immuno-oncology.(2022)
Authors: Jenny Sprooten, An Coosemans, Abhishek Garg
Patents
1 - 1 of 1